Delivery Order SPE2DR25D2009-SPE2DR26FJ4D8
- Not listed
- The Defense Logistics Agency awarded a $20,062.40 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on November 25, 2025, with completion targeted for November 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Zepbound 7.5 mg/0.5 mL pen injections valued at $10,966.72. The order was awarded on November 3, 2025, on a firm fixed-price basis with an ultimate completion date of November 4, 2025, with no set-aside designation applied. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,041.46 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This is a firm fixed price, non-set-aside contract with a completion date of June 20, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections with a ceiling value of $11,495.35. This is a firm fixed price delivery order with an ultimate completion date of December 10, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this...
- The Defense Logistics Agency awarded a delivery order valued at $13,757.09 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on December 1, 2025, with completion expected by December 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $11,125.18 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 18, 2025, and performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with a ceiling value of $3,410.78. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of October 24, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,107.42 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on December 2, 2025, with an ultimate completion date of December 3, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors valued at $4,448.25. This is a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ4D8Delivery Order
The Defense Logistics Agency awarded a $2,755.80 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors. The contract is a firm fixed price delivery order with an ultimate completion date of December 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made without a set-aside designation, indicating competitive procurement. As a child contract, this delivery order likely falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion pharmaceutical prime vendor agreement running through December 2026 that enables the contractor to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor headquartered in Conshohocken, Pennsylvania, with an extensive portfolio of federal contract awards predominantly through the Defense Logistics Agency's Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award of Zepbound, a diabetes medication, reflects AmerisourceBergen's continued role in supplying specialty pharmaceuticals to federal military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 12/10/25 |